| Chromogranin A and its role in the pathogenesis of diabetes mellitus Z Herold, M Doleschall, A Kovesdi, A Patocs, A Somogyi Endokrynologia Polska 69 (5), 598-610, 2018 | 49 | 2018 |
| Pravastatin in preeclampsia: A meta-analysis and systematic review B Meszaros, DS Veres, L Nagyistok, A Somogyi, K Rosta, Z Herold, ... Frontiers in Medicine 9, 1076372, 2023 | 20 | 2023 |
| New therapeutic approaches for type 1 diabetes: Disease-modifying therapies G Nagy, TE Szekely, A Somogyi, M Herold, Z Herold World journal of diabetes 13 (10), 835, 2022 | 16 | 2022 |
| Tissue miRNA combinations for the differential diagnosis of adrenocortical carcinoma and adenoma established by artificial intelligence PI Turai, Z Herold, G Nyirő, K Borka, T Micsik, J Tőke, N Szücs, M Tóth, ... Cancers 14 (4), 895, 2022 | 16 | 2022 |
| Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system Z Herold, AM Szasz, M Dank World Journal of Gastrointestinal Oncology 13 (9), 1109, 2021 | 13 | 2021 |
| Role and function of granin proteins in diabetes mellitus Z Herold, M Doleschall, A Somogyi World Journal of Diabetes 12 (7), 1081, 2021 | 13 | 2021 |
| Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin‐like cell hyperplasia and autoimmune … Z Herold, M Herold, P Nagy, A Patocs, M Doleschall, A Somogyi Journal of Diabetes Investigation 11 (4), 865-873, 2020 | 13 | 2020 |
| Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment Z Herold, M Herold, K Rosta, M Doleschall, A Somogyi Diabetology & Metabolic Syndrome 12, 1-5, 2020 | 12 | 2020 |
| Prognostic factors in pseudomyxoma peritonei with emphasis on the predictive role of peritoneal cancer index and tumor markers S Blaj, D Dora, Z Lohinai, Z Herold, AM Szasz, J Herzberg, R Kodacsi, ... Cancers 15 (4), 1326, 2023 | 10 | 2023 |
| Modulated electro-hyperthermic (mEHT) treatment in the therapy of inoperable pancreatic cancer patients—A single-center case-control study FG Petenyi, T Garay, D Muhl, B Izso, A Karaszi, E Borbenyi, M Herold, ... Diseases 9 (4), 81, 2021 | 10 | 2021 |
| Prolonged exposition with hyperthermic intraperitoneal chemotherapy (HIPEC) may provide survival benefit after cytoreductive surgery (CRS) in advanced primary epithelial … M Acs, Z Herold, AM Szasz, M Mayr, S Häusler, P Piso Cancers 14 (14), 3301, 2022 | 9 | 2022 |
| Changes in the cochlear and retrocochlear parts of the auditory system in 19–39 and 40–60 years old patients with type 1 diabetes mellitus M Horváth, Z Herold, M Küstel, L Tamás, P Prekopp, A Somogyi, ... Plos one 18 (5), e0285740, 2023 | 7 | 2023 |
| Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer Z Herold, M Herold, J Lohinszky, AM Szasz, M Dank, A Somogyi World Journal of Clinical Cases 10 (20), 6825, 2022 | 7 | 2022 |
| High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancer Z Herold, M Herold, G Herczeg, A Fodor, AM Szasz, M Dank, A Somogyi World Journal of Clinical Cases 10 (13), 4084, 2022 | 7 | 2022 |
| Histopathological chromogranin A-positivity is associated with right-sided colorectal cancers and worse prognosis Z Herold, M Dank, M Herold, P Nagy, K Rosta, A Somogyi Cancers 13 (1), 67, 2020 | 7 | 2020 |
| Personalized indicator thrombocytosis shows connection to staging and indicates shorter survival in colorectal cancer patients with or without type 2 diabetes Z Herold, M Herold, J Lohinszky, M Dank, A Somogyi Cancers 12 (3), 556, 2020 | 7 | 2020 |
| Rare histologies and infrequent indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy A Rajha, P Piso, L Halmy, I Panczel, DS Nedelcut, Z Herold, AM Szasz, ... Anticancer Research 42 (7), 3681-3692, 2022 | 6 | 2022 |
| Clinical effect of various trimetazidine formulations in chronic coronary syndrome VL Nagy, Z Herold Orvosi Hetilap 161 (16), 611-622, 2020 | 6 | 2020 |
| The role of chromogranin-A and its derived peptide, WE-14 in the development of type 1 diabetes mellitus Z Herold, P Nagy, A Patócs, A Somogyi Orvosi Hetilap 156 (5), 163-170, 2015 | 6* | 2015 |
| The prediction analysis of microarray 50 (PAM50) gene expression classifier utilized in indeterminate-risk breast cancer patients in hungary: A consecutive 5-year experience M Dank, D Mühl, A Pölhös, R Csanda, M Herold, AK Kovacs, L Madaras, ... Genes 14 (9), 1708, 2023 | 5 | 2023 |
A. Marcell SzaszSemmelweis UniversityE-mailová adresa ověřena na: korb2.sote.hu